YE-NEO 001 / ImmunityBio - LARVOL DELTA

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. (clinicaltrials.gov) - P1 | N=16 | Active, not recruiting | Sponsor: NantBioScience, Inc. | Unknown status ➔ Active, not recruiting | Trial completion date: Dec 2020 ➔ Dec 2025 | Trial primary completion date: Dec 2019 ➔ Jul 2025

Enrollment closed • Trial completion date • Trial primary completion date • Breast Cancer • Colorectal Cancer • Gastrointestinal Cancer • Head and Neck Cancer • Hepatology • HER2 Breast Cancer • HER2 Positive Breast Cancer • Hormone Receptor Breast Cancer • Hormone Receptor Positive Breast Cancer • Liver Cancer • Lung Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Triple Negative Breast Cancer • HER-2

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. (clinicaltrials.gov) - P1; N=16; Not yet recruiting; Sponsor: NantBioScience, Inc.

Clinical • New P1 trial • Breast Cancer • Colorectal Cancer • Gastrointestinal Cancer • Head and Neck Cancer • Hepatology • HER2 Breast Cancer • HER2 Positive Breast Cancer • Hormone Receptor Breast Cancer • Hormone Receptor Positive Breast Cancer • Liver Cancer • Lung Cancer • Melanoma • Non Small Cell Lung Cancer • Oncology • Pancreatic Cancer • Solid Tumor • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Triple Negative Breast Cancer • HER-2

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers. (clinicaltrials.gov) - P1; N=16; Recruiting; Sponsor: NantBioScience, Inc.; Not yet recruiting ➔ Recruiting

Clinical • Enrollment open • Colorectal Cancer • Hepatology • HER2 Positive Breast Cancer • Hormone Receptor Positive Breast Cancer • Liver Cancer • Melanoma • Non Small Cell Lung Cancer • Pancreatic Cancer • Squamous Cell Carcinoma • Squamous Cell Carcinoma of Head and Neck • Triple Negative Breast Cancer • HER-2